Skip to main content
. 2020 Jun;26(6):1192–1200. doi: 10.3201/eid2606.191300

Table 2. Characteristics and birth outcomes of pregnant women with active syphilis treated with amoxicillin or ampicillin, by syphilis stage, Japan, 2010–2018*.

Category Early syphilis, n = 31 Late syphilis, n = 49 p value†
Age, y 26 (21–28) 25 (22–27) 0.63
Japanese 29/31 (94) 46/49 (94) 1.00
HIV co-infection
0/31
1/49 (2)
1.00
Diagnosis and treatment
Rapid plasma reagin titer at diagnosis 44 (27–64) 58 (29–83) 0.64
Amoxicillin 28/31 (90) 38/49 (78) 0.23
Ampicillin 3/31 (10) 11/49 (22)
Antimicrobial drug dosage, mg/d 1,500 (1,500–1,500) 1,500 (1,500–1,500) 0.56
Received 1,500 mg/d 26/31 (84) 35/49 (71) 0.22
Total duration of treatment, d‡ 30 (28–64) 78 (51–104) 0.004
Duration of treatment at delivery, d‡ 30 (26–56) 70 (29-98) 0.016
Gestational age at diagnosis, wk‡ 15.1 (11.1–27.5) 13.3 (12–25.6) 0.70
Gestational age at treatment, wk‡ 17.3 (13.3–28.7) 14.7 (13–26) 0.62
Gestational age at delivery, wk‡ 39.4 (38.1–40.6) 38.9 (37.7–40.5) 0.10
Time from treatment to delivery, wk‡
15.7 (0.4–25.9)
23 (16.7–27.2)
0.73
Birth outcomes
Live birth with congenital syphilis diagnosis 0/26 13/45 (29) 0.009
Stillbirth 0/26 1/45 (2)
Miscarriage 0/26 1/45 (2)
Birth weight, g‡ 2,902 (2,652–3,184) 2,942 (2,555–3,155) 0.88
Low birth weight, <2,500 g‡ 3/26 (12) 8/45 (18) 0.52
Very low birth weight, <1,500 g‡ 0/26 3/45 (7) 0.29

*Values are no./total (%) or median (interquartile range).
†Used the Student t-test for continuous variables and either the χ2 test or Fisher exact test for categorical variables.
‡Denominators varied because of missing data. Anywhere from 1 to 11 cases might be missing.